Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-003388

CHIEF MEDICAL OFFICER acquired 2,260 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Mark Alan CHIEF MEDICAL OFFICER 2021-06-30 Grant or award +2,260 $1.95 $4,399 12,260 D
Loading xslF345X03/form4-07022021_040710.xml…